Generics - Gastro-intestinals


Current filters:


Popular Filters

District Court rules not to prevent Dr Reddy's and Endo from challenging Ranbaxy

District Court rules not to prevent Dr Reddy's and Endo from challenging Ranbaxy


Indian pharma company Ranbaxy has been denied its request to prevent the US Food and Drug Administration…

Anti-viralsDr Reddy's LaboratoriesEndo InternationalGastro-intestinalsGenericsLegalNexiumRanbaxy LaboratoriesUSAValcyte

FDA revokes tentative approval of Ranbaxy’s generic Nexium and Valcyte


Indian generics drugmaker Ranbaxy Laboratories revealed in a Bombay Stock Exchange filing that it has…

Anti-viralsAstraZenecaGastro-intestinalsGenericsNexiumPfizerRanbaxy LaboratoriesRegulationSun PharmaceuticalUSAValcyte

EPIRUS and Livzon Mabpharm to develop biosimilars for China

EPIRUS and Livzon Mabpharm to develop biosimilars for China


EPIRUS Biopharmaceuticals has signed a royalty-bearing, multi-product collaboration agreement with Livzon…

Anti-Arthritics/RheumaticsBiosimilarsBOW015ChinaEPIRUS BiopharmaceuticalsGastro-intestinalsGenericsLicensingLivzon MabpharmRemicadeResearch

Esteve to launch new generic version of omeprazole

Esteve to launch new generic version of omeprazole


Pensa Pharma, subsidiary of Spanish pharmaceutical company Grupo Esteve, has launched a new formulation…

Esteve GroupGastro-intestinalsGenericsOmeprazoleProductionSpain

Actavis prevails in Lialda patent dispute in USA

Actavis prevails in Lialda patent dispute in USA


US generics major Actavis says that the US Court of Appeals for the Federal Circuit has reversed a lower…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsShireUSA

Amneal debuts generic Esomeprazole strontium in USA


Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

Hanmi launches esomeprazole product in USA despite AstraZeneca litigation

Hanmi launches esomeprazole product in USA despite AstraZeneca litigation


South Korea-based Hanmi Pharmaceutical has announced that Esomezol (esomeprazole strontium) for the treatment…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumEsomeprazole SodiumGastro-intestinalsGenericsHanmi PharmaceuticalLegalNexiumPharmaceuticalUSA

Zydus Cadila settles Asacol patent litigation in USA


Zydus Cadila, one of India’s largest privately-held pharmaceuticals companies, and affiliate Zydus…

ActavisAsacol HDGastro-intestinalsGenericsNorth AmericaPatentsWarner ChilcottZydus Cadila

AstraZeneca wins damages from Apotex

AstraZeneca wins damages from Apotex


Anglo-Swedish drug major AstraZeneca this morning said it welcomed the US District Court for the Southern…

ApotexAstraZenecaFinancialGastro-intestinalsGenericsNexium I.V.North AmericaPatentsPrilosec

Abraaj sells stake in Opalia Pharma to Recordati


The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

Impax Labs confirms patent challenge to Pfizer/UCB's Toviaz


US specialty drugmaker Impax Laboratories (Nasdaq: IPXL) yesterday confirmed that it has initiated a…

Gastro-intestinalsGenericsImpax LaboratoriesNorth AmericaPatentsPfizerToviazUCB

Shire prevails in US Lialda patent dispute with Watson


Ireland-headquartered drugmaker Shire's (LSE: SHP) subsidiary Shire Development has prevailed in its…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsPharmaceuticalShireWatson Pharmaceuticals

Prescription drug costs: USA versus UK


In the USA, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who…

Cardio-vascularEuropeGastro-intestinalsGenericsNorth AmericaPharmaceuticalPricing

Researchers bust a gut to improve gastrointestinal disorders market


Drugs to treat gastrointestinal disorders are due to see a significant price drop, as patents run out…

Gastro-intestinalsGenericsMarkets & MarketingPharmaceutical

Uptake of biosimilars will see Remicade and Humira sales decline in 2017


The TNF-alpha inhibitors infliximab (Janssen Biotech/Merck/Mitsubishi Tanabe's Remicade) and adalimumab…

BiotechnologyGastro-intestinalsGenericsGlobalHumiraMarkets & MarketingRemicade

Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan


SFJ Pharmaceuticals Group, a global drug development group of companies which provides a unique co-development…

dacomitinibDetrol LAGastro-intestinalsGenericsLegalMylan LaboratoriesNorth AmericaOncologyPatentsPfizerPharmaceuticalResearchSFJ Pharmaceuticals

Par Pharma acquires Handa's ANDA for generic Dexilant


USA-based Par Pharmaceutical (NYSE: PRX) has entered into an exclusive acquisition and license agreement…

DexilantGastro-intestinalsGenericsHanda PharmaceuticalsLicensingNorth AmericaPar PharmaceuticalsTakeda Pharmaceuticals




Back to top